12th May 2021 Content supplied by: Bio-Rad Laboratories (Clinical Diagnostics)
Bio-Rad Launches SARS-CoV-2 Variant RT-PCR Assays
Bio-Rad Laboratories, Inc. have launched SARS-CoV-2 Variant RT-PCR Assays for research use only (RUO). The assays can detect SARS-CoV-2 variants of concern, including P.1, B.1.351, and B.1.1.7, by distinguishing specific mutations in SARS-CoV-2 using reverse transcription PCR (RT-PCR) often prior to a next-generation sequencing (NGS) workflow for confirmation.
With the emergence of several SARS-CoV-2 variants of concern, public health researchers are looking for a quicker way to track the spread of these variants in a population. Laboratories that use NGS to track COVID-19 variants can detect these mutations more quickly and cost-effectively with the SARS-CoV-2 Variant RT-PCR Assays to more rapidly prioritize which samples to submit for NGS.
Visit bio-rad.com/COVIDVariantSurveillance for more information about the SARS-CoV-2 Variant RT-PCR Assays.
Date Published: 12th May 2021
Source article link: View